Eurofins-Cerep SA (EPA:ALECR)
France
· Delayed Price · Currency is EUR 16,100
0.00 (0.00%)
Jan 20, 2026, 11:30 AM CET
Eurofins-Cerep Revenue
Eurofins-Cerep had revenue of 18.26M EUR in the half year ending June 30, 2025, a decrease of -15.19%. This brings the company's revenue in the last twelve months to 38.86M, down -8.43% year-over-year. In the year 2024, Eurofins-Cerep had annual revenue of 40.49M, down -8.13%.
Revenue (ttm)
38.86M
Revenue Growth
-8.43%
P/S Ratio
2.34
Revenue / Employee
187.71K
Employees
207
Market Cap
90.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 40.49M | -3.58M | -8.13% |
| Dec 31, 2023 | 44.07M | -3.58M | -7.51% |
| Dec 31, 2022 | 47.65M | 6.01M | 14.45% |
| Dec 31, 2021 | 41.63M | 8.97M | 27.45% |
| Dec 31, 2020 | 32.67M | 1.66M | 5.35% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 28.49B |
| Sanofi | 46.72B |
| Sartorius Stedim Biotech | 2.97B |
| Ipsen | 3.93B |
| Adocia | 12.88M |
| Sensorion | 5.65M |
| ABIONYX Pharma | 4.33M |
| Crossject Société Anonyme | 4.07M |